✦ LIBER ✦

PCV56 THE COST-EFFECTIVENESS LANDSCAPE OF GENETIC TESTING WITH WARFARIN THERAPY

✍ Scribed by LM Meckley; MJF Austin; LP Garrison; DL Veenstra

Book ID: 118608261
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 67 KB
Volume: 10
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)68698-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Cost Effectiveness of Duplicate Geno

The Cost Effectiveness of Duplicate Genotyping for Testing Genetic Association

✍ Nathan Tintle; Derek Gordon; Dirk Van Bruggen; Stephen Finch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Cost-effectiveness of genotype-guided wa

Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation

✍ Julio A. Leey; Steve McCabe; Jennifer A. Koch; Toni P. Miles 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 715 KB

PCV56 Cost-Effectiveness of Dabigatran E

PCV56 Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil

✍ V. Nasciben; M.J.D.O. Figueiredo; F.C.D.C. Darrieux; L.S.P. Piegas; S.C.O. Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

A Cost-effectiveness Analysis of Genetic

A Cost-effectiveness Analysis of Genetic Testing in the Evaluation of Families with Hypertrophic Cardiomyopathy

✍ J. Ingles; J. McGaughran; P. Scuffham; J. Atherton; C. Semsarian 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Comparison of selection strategies for g

Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma : Effectiveness and cost-effectiveness

✍ Carolina M. Reyes; Brian A. Allen; Jonathan P. Terdiman; Leslie S. Wilson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

## Background: Molecular testing for hereditary nonpolyposis colorectal carcinoma (hnpcc) is becoming standard care and it is cost-effective compared with no genetic testing. however, the best strategy for detection of hnpcc gene carriers is unknown. ## Methods: We use a decision analytic model t

Cost-Effectiveness Model of Use of Genet

Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular Disease

✍ Dov Shiffman; Katherine Slawsky; Lauren Fusfeld; James J. Devlin; Thomas F. Goss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 355 KB